Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.

Hara T GeorgatzakouVassilis L TzounakasAnastasios G KriebardisAthanassios D VelentzasEffie G PapageorgiouArtemis I VoulgaridouApostolos C KokkalisMarianna H AntonelouIssidora S Papassideri

Published in: European journal of haematology (2017)

Deregulation of RBC homeostasis might involve diverse molecular pathways driving erythrocyte signaling and removal in rhEPO non-responders compared to responsive patients.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
red blood cell
prognostic factors
patient reported outcomes
stem cells
bone marrow
drug delivery
patient reported